Hepatitis B Therapeutics Competitive Landscape Report: 184 Molecules in the Pipeline - 1 Asset in Pre-registration Stage, 1 Asset in Phase III Development, and 36 Assets in Phase II Development
February 28, 2025 06:34 ET
|
Research and Markets
Dublin, Feb. 28, 2025 (GLOBE NEWSWIRE) -- The "Hepatitis B Therapeutics: Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven...
Hepatitis B Drug Pipeline Research Report 2024
April 18, 2024 11:44 ET
|
Research and Markets
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis B - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report outlays comprehensive insights of...
Global $35.63 Billion Hepatitis B Virus (HBV) Market to 2030: Focus on European Union, United States & Japan
February 23, 2021 08:28 ET
|
Research and Markets
Dublin, Feb. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Hepatitis B Virus (HBV) Market: 10 Year Demand Forecast & Impact of COVID-19 (2021-2030)" report has been added to ResearchAndMarkets.com's...